Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy

Klinische Padiatrie

Volumn 223, Issue 3, 2011, Pages 169-172

  Tauer, J T ^a   Gneuss A ^a   Lohse, J E ^a   Jurgens T ^a   Knofler R ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

desmopressin; platelet function; thrombocytopathies; whole blood

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BLOOD CLOTTING FACTOR 8; COLLAGEN TYPE 1; DESMOPRESSIN; RISTOCETIN; THROMBIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; HEMOSTASIS; HEREDITARY THROMBOCYTOPATHY; HUMAN; MALE; PRESCHOOL CHILD; SCHOOL CHILD; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPATHY; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADOLESCENT; ASPIRIN; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMOSTASIS; HEMOSTATICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; THROMBIN; VON WILLEBRAND FACTOR;

EID: 79956134175     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0031-1275347     Document Type: Article

References (25)

1. Balduini CL, Noris P, Belletti S et al,. In vitro and in vivo effects of desmopressin on platelet function. Haematologica 1999 84 891-896 (Pubitemid 29516919)
2. Bolton-Maggs PHB, Chalmers EA, Collins PW et al,. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006 135 603-633 (Pubitemid 44674072)
3. Coppola A, Di MG. Desmopressin in inherited disorders of platelet function. Haemophilia 2008 14 31-39
4. DiMichele DM, Hathaway WE. Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol 1990 33 39-45 (Pubitemid 20031291)
5. Galvez A, Gomez-Ortiz G, az-Ricart M et al,. Desmopressin (DDAVP) enhances platelet adhesion to the extracellular matrix of cultured human endothelial cells through increased expression of tissue factor. Thromb Haemost 1997 77 975-980 (Pubitemid 27239125)
6. Ghosh S, Rao AK. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen. Thromb Res 1993 70 417-422 (Pubitemid 23171428)
7. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005 130 3-10 (Pubitemid 40979127)
8. Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009 35 150-157
9. Horstman LL, Valle-Riestra BJ, Jy W et al,. Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res 1995 79 163-174
10. Huhn B, Hofmann A, Hofmann K et al,. Desmopressin testing in children with von Willebrand syndrome in haemostaseologic centers of Saxonia, Saxonia-Anhalt and Thuringia. Hamostaseologie 2009 29 S98-S102
11. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001 138 152-163 (Pubitemid 32812228)
12. Kanwar S, Woodman RC, Poon MC et al,. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 1995 86 2760-2766
13. Klingebiel T, Creutzig U, Chrisaras A et al,. Milestones of healthy policy and rare diseases. Klin Padiatr 2010 222 121-123
14. Kundu SK, Heilmann EJ, Sio R et al,. Characterization of an in vitro platelet function analyzer, PFA 100®. Clin Appl Thromb Hemost 1996 2 241-249 (Pubitemid 126699612)
15. Lethagen S. Desmopressin (DDAVP) and hemostasis. Ann Hematol 1994 69 173-180 (Pubitemid 24314385)
16. Mannucci PM, Aberg M, Nilsson IM et al,. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975 30 81-93
17. Mannucci PM, Ruggeri ZM, Pareti FI et al,. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands diseases. Lancet 1977 1 869-872 (Pubitemid 8079684)
18. Moake JL, Turner NA, Stathopoulos NA et al,. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986 78 1456-1461 (Pubitemid 17219507)
19. Parker RI. 1-Deamino-8-D-arginine vasopressin primes platelets to respond to subthreshold concentrations of agonists through a sodium dependent mechanism. Clin Res 1989 37 385A
20. Rolf N, Knoefler R, Bugert P et al,. Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families. Br J Haematol 2009 144 416-424
21. Streif W, Knöfler R, Eberl W. Inherited disorders of platelet function in pediatric clinical practice: a diagnostic challenge. Klin Padiatr 2010 222 203-208
22. Tauer JT, Lohse J, Konig S et al,. Investigations of platelet function in whole blood with BAPA as anticoagulant. Transfus Med Hemother 2010 37 284-288
23. Wun T. Vasopressin and platelets: a concise review. Platelets 1997 8 15-22
24. Wun T, Paglieroni TG, Lachant NA. Desmopressin stimulates the expression of P-selectin on human platelets in vitro. J Lab Clin Med 1995 126 401-409
25. Yang X, Disa J, Rao AK. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets. Thromb Res 1990 59 809-818 (Pubitemid 20314049)